The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure
- PMID: 32579965
- PMCID: PMC7376235
- DOI: 10.1016/j.bpj.2020.05.033
The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure
Abstract
Amyloid-β (Aβ) is a macromolecular structure of great interest because its misfolding and aggregation, along with changes in the secondary structure, have been correlated with its toxicity in various neurodegenerative diseases. Small drug-like molecules can modulate the amyloid secondary structure and therefore have raised significant interest in applications to active and passive therapies targeting amyloids. In this study, we investigate the interactions of epigallocatechin-3-gallate (EGCG), found in green tea, with Aβ polypeptides, using a combination of in vitro immuno-infrared sensor measurements, docking, molecular dynamics simulations, and ab initio calculations. We find that the interactions of EGCG are dominated by only a few residues in the fibrils, including hydrophobic π-π interactions with aromatic rings of side chains and hydrophilic interactions with the backbone of Aβ, as confirmed by extended (1-μs-long) molecular dynamics simulations. Immuno-infrared sensor data are consistent with degradation of Aβ fibril induced by EGCG and inhibition of Aβ fibril and oligomer formation, as manifested by the recovery of the amide-I band of monomeric Aβ, which is red-shifted by 26 cm-1 when compared to the amide-I band of the fibrillar form. The shift is rationalized by computations of the infrared spectra of Aβ42 model structures, suggesting that the conformational change involves interchain hydrogen bonds in the amyloid fibrils that are broken upon binding of EGCG.
Copyright © 2020. Published by Elsevier Inc.
Figures
Similar articles
-
Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ42 Protofibril.ACS Chem Neurosci. 2020 Jun 17;11(12):1841-1851. doi: 10.1021/acschemneuro.0c00277. Epub 2020 Jun 5. ACS Chem Neurosci. 2020. PMID: 32441920
-
Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.J Phys Chem B. 2024 Feb 29;128(8):1843-1853. doi: 10.1021/acs.jpcb.3c07232. Epub 2024 Feb 15. J Phys Chem B. 2024. PMID: 38359305
-
Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ42 aggregation and disruption of Aβ42 protofibril: similarities and differences.Phys Chem Chem Phys. 2021 Sep 14;23(34):18843-18854. doi: 10.1039/d1cp01913a. Epub 2021 Aug 23. Phys Chem Chem Phys. 2021. PMID: 34612422
-
Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.Acc Chem Res. 2014 Feb 18;47(2):603-11. doi: 10.1021/ar4002075. Epub 2013 Dec 24. Acc Chem Res. 2014. PMID: 24368046 Review.
-
Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases.Front Neurosci. 2021 Sep 14;15:718188. doi: 10.3389/fnins.2021.718188. eCollection 2021. Front Neurosci. 2021. PMID: 34594185 Free PMC article. Review.
Cited by
-
Identification of Catechins' Binding Sites in Monomeric Aβ42 through Ensemble Docking and MD Simulations.Int J Mol Sci. 2023 May 3;24(9):8161. doi: 10.3390/ijms24098161. Int J Mol Sci. 2023. PMID: 37175868 Free PMC article.
-
Zinc-Epigallocatechin-3-gallate Network-Coated Nanocomposites against the Pathogenesis of Amyloid-Beta.ACS Appl Mater Interfaces. 2023 Feb 15;15(6):7777-7792. doi: 10.1021/acsami.2c20334. Epub 2023 Feb 1. ACS Appl Mater Interfaces. 2023. PMID: 36724494 Free PMC article.
-
Amyloid Disassembly: What Can We Learn from Chaperones?Biomedicines. 2022 Dec 17;10(12):3276. doi: 10.3390/biomedicines10123276. Biomedicines. 2022. PMID: 36552032 Free PMC article. Review.
-
Inhibition Mechanisms of (-)-Epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of Alzheimer's Disease via Molecular Simulations.ACS Omega. 2022 May 31;7(23):19665-19675. doi: 10.1021/acsomega.2c01412. eCollection 2022 Jun 14. ACS Omega. 2022. PMID: 35721940 Free PMC article.
-
Destabilization potential of beta sheet breaker peptides on Abeta fibril structure: an insight from molecular dynamics simulation study.RSC Adv. 2021 Jul 5;11(38):23557-23573. doi: 10.1039/d1ra03609b. eCollection 2021 Jul 1. RSC Adv. 2021. PMID: 35479797 Free PMC article.
References
-
- Alzheimer’s Association 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;14:367–429.
-
- Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356. - PubMed
-
- Dohler F., Sepulveda-Falla D., Glatzel M. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease. Brain. 2014;137:873–886. - PubMed
-
- Teplow D.B., Lazo N.D., Stanley H.E. Elucidating amyloid β-protein folding and assembly: a multidisciplinary approach. Acc. Chem. Res. 2006;39:635–645. - PubMed
-
- Mousseau N., Derreumaux P. Exploring the early steps of amyloid peptide aggregation by computers. Acc. Chem. Res. 2005;38:885–891. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
